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Summary.-[3H]-TdR and [3H]-UdR labelling indices and mitotic indices were
followed in tumour-bearing mice after application of either 5-fluorouracil (FU)
alone or of FU followed by cold TdR infusion. With FU alone, accumulation of
cells at the beginning of S was found, but there was no indication of a synchronous
passage of the accumulated cells further round the cycle. When FU injection was
followed by cold TdR infusion, a synchronous passage of the accumulated cells
through the cycle was observed. However, there was a large variation in the response
of individual mice to this treatment.
IN recent years, the concept of cell-
cycle-specific therapy oftumours following
synchronization of the tumour cells has
found increasing attention. Three sub-
stances which have been used clinically
to achieve synchrony are hydroxyurea
(Sauer, Pelka and Wilmanns, 1976), vin-
cristine (Klein and Lennartz, 1974) and
5-fluorouracil (FU) (Nitze, Ganzer and
Vosteen, 1974). However, the efficacy of
vincristine as a synchronizing agent has
been disputed (Jellinghaus et al., 1975).
In addition, Wannenmacher et al. (1974)
were unable to confirm the results ob-
tained by Nitze et al. (1974) with FU.
As this form ofclinical synchronization
therapy is being widely used, it was
decided to carry out the present study
with FU. The aim of the present study
was to see if in vivo synchrony can, in
fact, be achieved with FU. For this
purpose, the mouse L1210 leukaemia was
used and the study was carried out in
two parts. In the first part the effect
of FU alone on the tumour cells was
studied. In the second part FU injection
was followed by a constant infusion of
cold TdR. This was done to see whether
the degree ofsynchrony could be improved
by cold TdR infusion. The possibility
of improving synchrony with cold TdR in
vitro has already been demonstrated
(Eidinoff and Rich, 1959; Rueckert and
Mueller, 1960).
In a strict sense one can speak about
synchronization only if two important
conditions are fulfilled. The first condi-
tion is that an efficient accumulation of
cells at a particular point in the cell
cycle be produced. As is described later,
the action of FU meets this condition,
at least in part. However, it will also
be seen that the action of FU alone does
not meet the second condition, that
after a suitable time a rapid dissolution
of the block occurs, leading to a sharp
release of accumulated cells and their
subsequent synchronous passage round
the cycle.
MATERIAL AND METHODS
5-Fluorouracil (FU) was obtained from
Hoffmann-La Roche, Grenzach/Baden.
[3H-Methyl] thymidine ([3H]-TdR, sp.
act. 6-7 Ci/mmol) and [3H-6]-deoxyuridine
[3H]-UdR, sp. act. 25-9 Ci/mmol) were ob-
tained from New England Nuclear Chemicals,
Boston, Mass., USA.
Cold TdR was purchased from the Sigma
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Animals.-The experiments were carried
out on female B6D2 Fl mice (Laboratory
of Animal Breeding and Research Centre,
GI Bomholtgard Ltd, Ry, Denmark). The
mice weighed 20-27 g. They were kept
under constant conditions (12-h light-dark
regime, Altromin R standard food, water ad
lib.).
Transplantation ofL1210 ascites tumour.-
Initially the tumour was transplanted at
6-day intervals. Ascitic fluid was pooled
from 3 mice. Each recipient mouse received
105 cells i.p. in a volume of 0-1 ml. Experi-
ments were begun on the 5th day after
transplantation.
The above method was used for the
part of the study which will be described
first. After 180 passages the L1210 cell
line maintained in this institute ceased to
grow normally, and new cells had to be
obtained from Dr Bierling, Inst. f. Onkologie
und Immunologie, Hauptfabriken Bayer,
Wuppertal-Elberfeld, Germany. For the
second part of the study (cold TdR infusion
experiments), the transplantation procedure
carried out at Bayer was adopted. The
tumour was transplanted at weekly intervals
and each recipient mouse received 2 x 105
cells in a volume of 0-2 ml. Experiments
were begun on the 6th day after trans-
plantation. The mean survival time of
mice transplanted in this way is 12-5 days.
During the experimental period, the mitotic
index remained constant in untreated animals
and there was only a small fall in labelling
index.
Constant infusiontechnique.-The constant
infusion technique was carried out as de-
scribed by Lobbecke, Schultze and Maurer
(1969). A catheter was inserted into the
tail vein of mice on the day before the
experiment began. For 24 h before the
start of the experiment physiological saline
was infused. At the appropriate time, the
infusion medium for mice to receive cold
TdR was changed to TdR solution (36 mg
TdR in 20 ml 5% glucose solution). The
control mice (without TdR) were maintained
for the duration of the experiment on the
physiological saline infusion. All infusions
were given at a rate of 2-4 ml/day. During
the experiment the mice were able to move
around freely, and eat and drink at will.
To obtain samples of ascites fluid from
the mice under constant infusion, a small-
bore needle (Nr. 18 or 20) was carefully
inserted into the peritoneal cavity and one
drop of ascites fluid withdrawn. This pro-
cedure was repeated 8-10 times during the
course of the experiment.
Histology and autoradiography.-Smears
were prepared from the ascites, air-dried,
fixed in methanol and Feulgen-stained.
Autoradiographs were prepared by the
dipping technique, with Ilford K2 emulsion.
They were exposed at 4°C and developed
with Amidol.
Evaluation ofslides. Mitotic and labelling
indices were determined by counting a
minimum of 1000 cells for each animal or,
in the case of multiple-sampled mice, 1000
cells for each individual sample.
Biochemical action of 5-fluorouracil
The main effect of FU is to block the
enzyme TdR synthetase (TS), which by
methylation converts deoxyuridine phos-
phate to deoxythymidine phosphate (see
Fig. 1). When deprived of deoxythymidine
phosphate, cells are unable to synthesize
DNA and therefore accumulate at the
beginning of S. The active metabolite is
not, however, FU itself but FUdRP. FU
can also affect RNA synthesis, but the
doses required to produce an observable
effect on RNA synthesis are considerably
higher (Heidelberger et al., 1960; Hartmann
and Heidelberger, 1961).
An important factor limiting the efficiency
of accumulation of cells by FU is the so-
called " thymidine salvage pathway ".
Through this pathway cells are able to take
up from their surroundings and reutilize
TdR produced by catabolism of dead cells.
By the action of TdR kinase (TK), the
TdR enters the normal pathway of DNA
synthesis as deoxythymidine phosphate (Fig.
1). It is well known that, particularly in
vivo, this pathway can provide proliferating
cells with a significant proportion of their
TdR requirements. (See for example Clea-
ver, 1967).
As can be seen in Fig. 1, TdR enters
the DNA synthesis pathway at a point
after the action of TS, and its incorporation
is thus unaffected by FU. This fact also
explains an important difference between
the incorporation of [3H]-UdR and [3H]-TdR
into cells treated with FU. [3H]-TdR incor-
poration does not proceed via the enzyme
TS, and thus no reduction of incorporation
is to be expected after application of FU.
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FIG. 1. Metabolism of 5-fluorouracil.
The block of this enzyme cannot therefore
be directly measured with [3H]-TdR. In
contrast, [3H]-UdR incorporation can only
proceed via TS (Fig. 1) and this compound
does allow a direct assessment ofthe efficiency
of the FU block.
After a period of FU-induced blockage
of DNA synthesis it should be possible to
release cells more quickly from the effects
of the block by supplying them with exo-
genous TdR. If sufficient TdR is available,
it can be incorporated by the action of TK
into the main DNA synthesis pathway and,
even with a fully blocked de novo synthesis
of deoxythymidine phosphate, allow cells
to progress through the S phase. By this
means, a sharper release of cells from the
FU block should be achieved. As stated
earlier, this has indeed been demonstrated in
vitro (Eidinoff and Rich, 1959; Rueckert and
Mueller, 1960).
RESULTS
Determination ofFU dose
The first part of this investigation
involved experiments to determine a
suitable dose of FU which results in an
effective but reversible block of cells at
the beginning of S. To assess the re-
sponse of the L1210 tumour cells to a
range of FU doses (0-1; 1; 3; 10; 30;
100 ,tg/g body wt) mitotic and [3H]-UdR-
labelling indices were determined before,
and at various times (1; 10; 48 h) after,
injection of FU.
The results for doses of 0-1, 3, 30 and
100,ug/g FU are illustrated in Fig. 2.
A dose of 0-1 jtg/g caused a sharp initial
fall in mitotic index (Fig. 2(a)). In
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Fia. 2.-Response of L1210 tumour cells to a
range of FUdoses (0. 1; 3; 30 and 100 ,g/g).
(a) Mitotic index, (b) [3H]-UdR-labelling
index as a function of time after FU injec-
tion. For simplicity, experimental points
are not shown. For each dose, indices
were measured before and at 1-5, 10 and
48 h after FU injection. The number of
mice per time point varied from 2 to 9
for all doses studied. The full data for
3 ,ug/g FU is given in Fig. 3.
addition, [3H]-UdR grain count wa
reduced to about half of the norma
value 1-5 h after application of FU
However, there was no depression o
[3H]-UdR-labelling index following Fl
(Fig. 2(b)). The block of TS was clearl:
far from complete. Doses of 100 an
30 ,ug/g FU caused an irreversible decreaso
of both mitotic and [3H]-UdR-labellinj
indices. No recovery of the proliferativl
indices was seen for the duration of tho
experiment (48 h). Moreover, there wa
evidence of cell killing with these tw(
highest doses. In contrast, a dose o
3 ,tg/g FU caused an initial sharp de
pression of both mitotic and labelling
indices, followed by a peak of 800/,
labelled cells 10 h after FU, and norma
indices 48 h after FU. As with th
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other doses in the range 041 to 10 utg/g,
no evidence of cell killing was seen.
One ,tg/g and 10 ,ug/g FU had an
effect on the mitotic index similar to
that of 3 ,tg/g. Differences resulted, how-
ever, in the response of the [3H]-UdR-
labelling index. Though there was a
marked reduction in grain count per
nucleus 1.5 h after a dose of 1 /ug/g, the
labelling index was little affected; thus
the block of TS was less effective than
with a dose of 3 /tg/g. After application
of 10 jtg/g FU, recovery of labelling
index was much slower than after a
dose of 3 ,ug/g. Ten hours after FU
injection, only 10% [3H]-UdR-labelled
cells were found (in contrast to nearly
80% labelled cells with 3 ,ug/g FU).
On the basis of these results, 3 ,ug/g
FU was chosen as the most likely dose
to give a synchronizing effect, as it
caused a substantial initial block followed
later by recovery of proliferative indices.
This dose lies between the highest doses,
which caused an irreversible block and
resulted in cell killing, and the lower
doses, which were less effective in blocking
TS.
Action of 3 ,ug/g FU alone
After the choice of 3 ,ug/g FU as the
most suitable dose, more extensive studies
ofthe mitotic index and the incorporation
of [3H]-UdR and [3H]-TdR were made.
Fig. 3 shows the results.
(a) Mitotic index.-Fig. 3(a) demon-
strates the mitotic index for singly
sampled mice; groups of mice were
killed at the various time points and a
single sample of ascites fluid withdrawn.
As can be seen, the curve shows a sharp
decrease, reaching a minimum 8 h after
injection of FU. This trough is followed
by a slow rise to approximately normal
values, with no evidence of a mitotic
peak.
To see whether repeated withdrawal
of ascites fluid affected the mitotic index
per se, an experiment was carried out
in which 4 mice were given 3 ,tg/g FU,
and each mouse was then sampled 10
38
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hafter FU injection
labelled [3H]UdR labelling
cells 4
(b) /
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0,0
labelled
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IU LU JU 4U DU
h after FU injection
FiG. 3.-The effect of 3 ,ug/g FU on (a)
mitoticindex; (b) [3H]-IJdR-labellingindex,
(c) [3H]-TdR labelling index. The dashed
line in (c) shows the [3H]-TdR-labelling
index over this period in the absence of
5-FIJ. Each point represents the mean
value of 2-9 animals; where 3 or more
animals were present in a group, s.e. mean
is shown.
/omitoses 4
3
2
1
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h after FU injection
Fie. 4.-Mitotic index with multiple sampling
following 3 ,ug/g FIJ. The solid line shows
the course of the mitotic index in mice
sampled only once. This curve is given
fully, with individual points and s.e. in Fig.
3(a). The points in this figure are the
mean values for a group of 4 mice, from
each of which 10 small samples of ascites
were withdrawn during the experimental
period; s.e. mean indicated.
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times over a period of 35 h. The results
are given in Fig. 4. The course of the
mitotic index for multiply-sampled mice
(points, Fig. 4) was found to be essentially
the same as obtained from groups of
singly-sampled mice (curve, Fig. 4). Thus,
multiple sampling as carried out here
had no significant effect on the mitotic
index.
(b) [3H]-UdR labelling.-The [3H]-
UdR-labelling index curve is given in
Fig. 3(b). As described previously, a
sharp fall is seen after injection of FU,
and this is followed by a peak of almost
80% labelled cells after 10 h, and nearly
normal values after 48 hours. A mini-
mum of 10% labelled cells is seen at
5 h; the few labelled cells at this time
have a median grain count only one-tenth
the value of controls without FU, and
thus [3H]-UdR incorporation is more
sharply reduced than the labelling index
alone would indicate. Recovery of grain
count to normal values is slow: although
80% labelled cells are seen 10 h after
FU, the median grain count is only one
6th of control values. At 48 h the
median grain count in FU-treated mice
is about three-quarters the control level.
(c) [3H]-TdR.-The [3H]-TdR-label-
ling results after 3 ,tg/g FU are illustrated
in Fig. 3(c). As expected, no fall in
[3H]-TdR-labelling index was seen after
injection of FU: instead there was a
steady rise to a peak value of about
80% at 8 h. This value was similar
to that obtained with [3H]-UdR at the
same time. The grain count remained
approximately normal over the period
of the experiment. After the peak label-
ling index, a slow decrease occurred,
normal values being reached about 20 h
after FU injection.
FU application followed by cold TdR
infusion
As was stated earlier, it is possible
to achieve in vitro partial synchrony,
which persists at least up to the sub-
sequent mitosis, by sharpening the release
ofcells from the FU block with thymidine.
a iu LU JU h after first FU inject'ian
FU cold TdR infusion
t t
3ug/g
FIG. 5. (Cold TdR constant infusion experi-
ments. Experimental design and mitotic
curves for a group of 8 mice (with TdR
(solid line) and 6 mice without TdR (dotted
line). s.e. indicated.
To examine this possibility in vivo, FU
injection in tumour-bearing mice was
followed by constant infusion of cold
TdR.
(a) Experimental design and results.
Fig. 5 illustrates the experimental design
and also the mean mitotic index curves
obtained for a group of 8 experimental
and 6 control mice. All mice were
given 3 ,tg/g FU i.p. at the beginning of
the experiment and again 2-5 h later.
The second injection was given to ensure
a maximum block for the 5-h period
calculated to be necessary for entry of
all G1, G2 and M cells into S. Continuous
infusion of FU over this 5-h period was
tried but found not to improve accumula-
tion of cells at the beginning of S.
Five hours after the first FU injection,
one group of 8 mice was infused i.v.
with cold TdR, while a control group
of 6 mice was maintained on physio-
logical saline infusion. The rate of TdR
infusion was 3 ,ug/mouse/min. This rate
was calculated, from the work of Stewart
et al. (1965) and Lee et al. (1976) to be
sufficient to provide the mice with enough
TdR for normal requirements in the
absence of de novo synthesis. A drop
of ascitic fluid was withdrawn from
each mouse 8 times during a 28-h
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period. The mitotic index was deter-
mined for all samples.
The solid line (Fig. 5) indicates the
course of the mitotic index for the mice
which received FU followed by cold
TdR: the points are mean values for
the group of 8 mice; standard errors are
shown. For comparison, the dotted
line gives the resulting means for the
group of 6 control mice given FU but
no cold TdR. As can be seen, a peak
mitotic index was obtained in the cold
TdR-treated mice. In fact, the cold
TdR group have a significantly higher
mitotic index over the period 8 to 23 h
after the first FU injection (Mann-
Whitney test). The peak mitotic index
in the cold TdR group occurred at 19 h
I
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FIG. 6.-Mitotic index curves for individual
cold TdR mice. These mice received FU
followed by cold TdR infusion. Each solid
line represents one experimental mouse.
The broken line in each graph is the mean
for 6 mice without TdR.
after the first FU injection. This is
14 h after the beginning of the cold TdR
infusion. If cells blocked at the beginn-
ing of S had passed at the normal rate
around the cycle at the start of cold
TdR infusion, they would have been
expected to reach mitosis in a time
equal to S + G2 + 1 M; this is about
8-9 h in this tumour. Thus, the peak
of mitoses occurred somewhat later than
expected.
(b) Mitotic results for individual mice
infused with cold TdR.-The variation
in response of individual mice to FU
treatment followed by cold TdR infusion
is seen in Fig. 6. The mitotic curves
for the 8 cold TdR mice are given by
the solid lines. These are the individual
curves, whose average is plotted as the
solid line in Fig. 5. Once again, for
comparison, the mean curve for the
control group is given in each case. As
can be seen, not only does the height
of the mitotic peak vary greatly, but also
its timing and shape.
(c) Labelling index results.-In addi-
tion to the mitotic index measurements,
[3H]-TdR-labelling indices were also deter-
mined in both the control and cold TdR
groups of mice. It was, of course, only
possible to measure the [3H]-TdR labelling
index at one time for each mouse. The
labelling index was measured in 4 mice,
5 h after the first FU injection. This
was done to assess the percentage of
cells accumulated at the beginning of S
in this 5-h period. At the time of the
mitotic peak in the cold TdR mice
(Fig. 5), 19 h after the first FU injection,
the labelling index was also determined
for groups of 4 control and 4 cold-TdR
mice.
At the end of the FU block period
(Table; 5h) approximately 70% labelled
cells were seen. This is about 20% more
than the normal value of 50% (Table;
0 h) and indicates an accumulation of
20% of the cells at the beginning of S.
Nineteen hours after the first FU injection
the control mice without cold TdR had a
mean mitotic index of 1.8%, and no
cn
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0
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TABLE.-[3H]-TdR-labelling Indices Fol-
lowing FU Application Alone and FU
Application Plus Cold TdR Infusion
Number h after Labelling
Animal of FU index %
group mice injection (mean+s.e.)
Untreated control 6 0 50 0 2*5
FUonly 4 5 68-0±2-6
FU only 4 19 70-0±3 9
FU+cold TdR 4 19 49-1±3-6
evidence ofa mitotic peak (Fig. 5-dotted
line). Atthistime, thelabellingindex was
still 70%, indicating that the accumulated
cells had not yet left the S phase. In
contrast, the cold TdR mice 19 h after the
first FU injection had a mean mitotic
index of 4.4% (Fig. 5-solid line). At
this time the mean labelling index for
the cold TdR mice was reduced to 49%
(Table; 19 h). This is further evidence
that the cold TdR infusion had, indeed,
led to a faster release of the cells blocked
by FU. The accelerated passage of these
cells through the S phase into mitosis
leads to the mitotic peak shown in
Fig. 5 (solid line).
DISCUSSION
Action ofFU alone
The mitotic and labelling results (Fig.
3(a-c)) with FU alone, showed that we
achieved a considerable, but not complete,
block of cells at the beginning of the
S phase. If a complete block had been
achieved, the mitotic index would have
reached zero. It is known that the rate
of entry of cells into S in this tumour is
7%/h: thus, after 5 h one would have
expected to have accumulated 35% of
the cells at the beginning of S, if the
block had been complete. The [3H]-TdR
curve (Fig. 3(c)) shows that, in fact, a
little over 20% of the cells were accu-
mulated. The [3H]-UdR-labelling results
(Fig. 3(b)) indicated that over the first
5 h after FU the block of TS was almost
complete (only 10% very lightly labelled
cells were seen at 5 h). The main factor
preventing a better block is almost
certainly the TdR available to the cells
via the " thymidine salvage " pathway.
The [3H]-UdR and mitotic index
curves (Fig. 3(a) and (b)) suggest that
cells begin to escape from the block by
about 10 h after application of FU, but
this release is slow and gradual. There
is no evidence (Fig. 3(c)) of a second
peak of labelled cells. Furthermore, no
peak of mitotic index is seen after the
labelling-index peak. Instead, the mito-
tic index rises slowly, reaching normal
values 30 h after FU injection. If accu-
mulated cells had been released sharply,
they would have required a period equal
to the duration of S and G2 to reach
mitosis: about 8-9 h in the L1210 tumour.
Under this condition, a peak of mitotic
activity would have been seen 16 to
20 h after FU. This was clearly not the
case (Fig. 3(a)). Thus, the cells accumu-
lated at the beginning of S do not pass
through mitosis in a synchronized wave,
and it would seem that FU does not,
at least in this study, fulfil the second
requirement of a synchronizing agent
(i.e. the accumulated cells do not escape
sharply from the block and do not pass
synchronously further round the cycle).
This failure of the accumulated cells
to pass synchronously round the cycle
could be due either to a slow dissolution
of the block or to their sustaining per-
manent damage leading to a complete
failure to proliferate further, and eventual
death. With a dose of 3 ,ug/g FU, no
cytological evidence of cell death was
seen, in contrast to higher doses. Thus,
the most likely explanation for the failure
to achieve synchrony was a slow release
of cells from the block. Schumann and
Hattori (1975) found, with a hamster
sarcoma cell line in vitro, that passage
of cells round the cycle after FU treat-
ment was markedly slowed. They found
that cells which normally had an S phase
of 8-1Oh required 72 h to pass from the
beginning of S to G2 after FU.
A possible reason for the slow recovery
of cells from the effects of FU may be
the long life of active FU metabolites,
particularly FUdRP, in the tissues. Al-
though a large part of injected FU is
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excreted rapidly (Chaudhuri, Montag and
Heidelberger, 1958), evidence from studies
with 14C-labelled FU suggests that active
metabolites are present in the tissues for
periods up to 72 h after injection (Chad-
wick and Rogers, 1972; Liss and Chad-
wick, 1974). FU has also been shown
to have long-lasting effect on [3H]-UdR
incorporation into tumour cells (Kovacs et
al., 1975; Myers, Young and Chabner,
1975). Myers et al. (1975) found that a
dose of 15 ,ug/g FU caused depression
of [3H]-UdR incorporation in an ascites
tumour, lasting 72 h. These authors
showed that the recovery of [3H]-UdR
incorporation depends not only on the
rate of recovery of DNA synthesis but
also on changes in metabolite pool sizes
within the cells. Such biochemical factors
may well explain the observed slow
recovery of [3H]-UdR grain count in
the present study. If this is the case,
[3H]-UdR incorporation after FU applica-
tion is not directly proportional to the
rate of DNA synthesis. Thus, although
[3H]-UdR is useful to demonstrate onset
of the block of DNA synthesis, because
of changes in incorporation rate due to
changes in metabolite pool sizes, [3H]-
UdR does not allow a direct assessment
of the rate of recovery of DNA synthesis
after FU.
Effect of FU followed by cold TdR
When injection of FU was followed
by constant infusion with cold TdR,
evidence of a synchronized passage of
cells round the cycle was seen. In all
animals which received cold TdR, there
was an increase in mitotic index in the
period 3-18 h after the beginning of the
TdR infusion. The mitotic peaks were,
however, generally broad and fairly small
(Fig. 6). That the peaks were not higher
is not surprising, in view of the fact that
accumulation of cells by FU was only
partial. Also, in view of the known
variation of S phase duration in the
L1210 tumour, considerable flattening of
the mitotic peaks would be expected.
The peak mitotic index in Fig. 5 occurred
14 h after the start of the cold TdR
infusion. If the accumulated cells had
passed through S and G2 at the normal
rate, they would have been expected
to reach mitosis 8-9 h later (S + G2).
No firm explanation for this delay of
about 5 h is available. One possibility
is that the dose of cold TdR was not
quite optimal, and therefore DNA syn-
thesis took longer than normal. It is
possible that, if a slightly higher dose
had been given, the peak of mitoses
would have been seen earlier. A range
of cold TdR doses was not tested, simply
due to the practical limitations of the
constant infusion technique, which allows
only a small number of mice to be infused
at any one time.
In vitro and in vivo studies with animals
It has clearly been shown in vitro that
the growth-blocking effect ofFU or FUdR
on proliferating cultured cells can be
prevented by supplying the cells with
exogenous TdR (Brinkmann and Dormer,
1972; Madoc-Jones and Bruce, 1968;
Rich et al., 1958; Umeda and Heidel-
berger, 1968). Further, cells accumulated
at the beginning of the S phase by these
compounds have been shown, when re-
leased from this block by added TdR,
to proceed in a partially synchronized
wave round the cell cycle, at least as
far as the subsequent mitosis (Eidinoff
and Rich, 1959; Rueckert and Mueller,
1960).
In vivo studies in animals of the
problem of synchronization with FU are
few in number. Jentzsch (1975), using
a dose of 13 ,ug/g FU with the rat Walker
tumour, found no effect on mitotic or
labelling index. An effect on the PLM*
curve in animals given FU compared
with controls was found, but is difficult
to explain. Ganzer and Nitze (1970) and
Nitze et al (1974) reported investigations
on chemically induced skin tumours of
* % labelled metaphases.
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mice. In these studies, life-span of the
animals and rate ofgrowth ofthe tumours
were assessed for 5 groups of mice.
One group (" combination therapy
group) received FU and irradiation
separated by an interval of one day,
while another group (" synchronously "
treated group) received FU over a 12-h
period followed 8 h later by irradiation.
It was assumed that the cells accumulated
by FU escaped sharply from the block
and passed in 8 h through S into the
radiosensitive G2 phase. It was found
that the second, so-called " synchronously
treated ", group had a longer survival time
and that the tumours in this group grew
more slowly than in the " combination
therapy " group. These differences were
ascribed to the effect of FU-induced
synchronization. However, no direct evi-
dence that synchrony had, in fact, been
achieved was presented (e.g. no labelling
or mitotic studies). There is no doubt
that there are timing factors other than
those relating to synchrony, which are
important for the success of combination
therapy. Thus caution should be exer-
cized in ascribing effects such as those
described above to synchrony.
Clinical studies with FU
FU has been used in the treatment
of malignant tumours for many years,
and there is no doubt that with certain
types of tumour its use, either alone or
in combination, can be clinically valuable.
The literature on the clinical use of
FU, particularly as part of combination
therapy schedules, is extensive. Its clini-
cal use as a synchronizing agent is,
however, more recent. Extensive inves-
tigations in this area have been made
by Nitze and co-workers (Ganzer and
Nitze, 1969; Nitze et al., 1974). The
results of these studies are reviewed in
the paper from Nitze et al. (1974). In
these studies FU was infused into tumour-
bearing patients for a period of 12 or
18 h and mitotic indices and labelling
indices were determined by in vitro
incubation with [3H]-TdR at various
times after cessation of the FU infusion.
A rise in labelling index was found
immediately after FU infusion, followed
8 hlaterby a fall. The increase was taken
as due to accumulation of cells at the
beginning of5, and the decline as showing
the progress of these cells into the G2
phase. Caution is perhaps necessary in
interpretation of these labelling results,
as the labelling was carried out in vitro,
and some ofthe samples were incubated in
vitro for up to 8 h before labelling. The
longer the time in vitro the less directly
can the values be assumed to relate to
the in vivo value. The mitotic index
curves obtained by these authors were
interpreted as indicating synchrony; how-
ever, a number of anomalies are evident.
Immediately at the end of the FU block,
only a very slight fall in mitotic index
was seen. If a sufficient block had
been achieved to cause clear synchrony,
one would have expected a more dramatic
fall in mitotic index. The main evidence
that synchrony had been achieved was
a small mitotic peak 9 h after the end
of the FU block. This peak was, how-
ever, small and its statistical significance
doubtful. The timing of the peak is
also of interest: the authors assumed an
S-phase duration of 8h, and they also
assumed that the accumulated cells imme-
diately after FU infusion began their
passage round the cycle at the normal
rate. From a survey of the literature,
the assumption concerning the duration
of S would not seem too secure. In
human tumours this has generally been
shown to be considerably longer than 8 h
(see for example Malaise, Chavaudra and
Tubiana, 1973). The assumption thatthe
cells at the end of the block immediately
begin to cycle at the normal rate is,
from the results presented in this paper,
equally doubtful.
Wannenmacher et al. (1974) treated
23 patients with squamous cell carcinoma
with the therapeutic scheme of Nitze et
al. (1974). Impulse cytophotometry was
used to follow the kinetic changes in the
tumours after FU infusion. In 15 of
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these patients there was no evidence
of a synchronized passage of cells into
the radiosensitive G2 phase after FU.
Even in the 8 patients in which an in-
creased G2 population was seen, this
occurred, not 9h after FU infusion, as
was assumed by Nitze et al. (1974), but
considerablylater.
As a result of our present studies and
those reported in the literature, it is
felt that the claims by Nitze et al. (1974)
that synchronization can be achieved in
vivo in patients, and that their timing
schedule is optimal for synchronization
therapy, should be treated with caution.
That the treatment schedule reported by
Ganzer et al. (1974) may yield good clinical
results is not disputed and has been
confirmed by other authors (Helpap et
al., 1977; Wannenmacher et al., 1974).
However, as pointed out by these other
authors, the positive clinical results prob-
ably depend upon factors other than
synchronization.
The present study with the L1210
tumour suggests that synchrony in vivo
with FU is not easily achieved, due to
three main factors. Firstly, the block
is incomplete, probably due to the " thy-
midine salvage pathway ". Secondly,
cells escape only slowly and gradually
from the effects of FU. Thirdly, there
is a high degree of variation in response
ofindividual tumours to the drug. When
FU was followed by constant infusion
of cold TdR, a small degree of synchrony
was achieved in this investigation with
mice. However, there was great varia-
tion in the response of individual animals.
One would expect an even greater varia-
tion between slowly growing human
solid tumours. Even if synchrony could
be achieved clinically, this variation
would make it very difficult to develop
treatment schedules of general relevance.
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